Related Experiment Videos
Gabapentin increases slow-wave sleep in normal adults.
Nancy Foldvary-Schaefer1, Isabel De Leon Sanchez, Matthew Karafa
1Department of Neurology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. foldvan@ccf.org
Epilepsia
|December 4, 2002
Summary
Gabapentin (GBP) did not significantly alter sleepiness or most sleep measures in healthy adults. However, gabapentin increased slow-wave sleep (SWS) and reduced sleep disruptions, suggesting it is less disruptive than older antiepileptic drugs.
Area of Science:
- Neuroscience
- Sleep Medicine
- Pharmacology
Background:
- Older antiepileptic drugs (AEDs) negatively impact sleep architecture, reducing REM sleep and slow-wave sleep (SWS).
- The effects of newer AEDs, such as gabapentin (GBP), on sleep patterns remain largely uncharacterized.
- Understanding GBP's impact on sleep is crucial for managing epilepsy and related sleep disorders.
Purpose of the Study:
- To investigate the effects of gabapentin (GBP) on sleep parameters in healthy adults.
- To compare the sleep-disrupting potential of GBP with older AEDs.
Main Methods:
- A polysomnography (PSG) study was conducted on 10 healthy adults and 9 controls.
- Subjects received gabapentin (GBP) titrated up to 1,800 mg daily.
- Sleep questionnaires, including the Epworth Sleepiness Scale (ESS), and polygraphic variables were analyzed.
Main Results:
- Gabapentin (GBP) treatment led to a significant increase in slow-wave sleep (SWS) compared to baseline.
- No significant changes were observed in Epworth Sleepiness Scale (ESS) scores or other major polygraphic sleep variables.
- A slight reduction in sleep arousals, awakenings, and stage shifts was noted in GBP-treated subjects.
Conclusions:
- Gabapentin (GBP) appears to have a less disruptive effect on sleep compared to some older antiepileptic drugs.
- The observed sleep benefits, including increased SWS and reduced disruptions, may contribute to GBP's efficacy in treating sleep-disordered conditions.